We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 24 AUGUST 2016
Minsalud Will Unilaterally Set Price Of Medicine For Leukemia
Clarke, Modet & Co
Everything seemed that the declaration of the Imatinib molecule to treat cancer as a matter of public interest, would be the third case of compulsory license in Latin America, after the...
ChileIntellectual Property




